These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8319860)

  • 21. Changes in regional body blood volume caused by nitroglycerin.
    Loos D; Schneider R; Schörner W
    Z Kardiol; 1983; 72 Suppl 3():29-32. PubMed ID: 6421012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obstructive pulmonary disease.
    Delaunois L; Jonard P; Kremer N; Dubois P; Lulling J
    Bull Eur Physiopathol Respir; 1984; 20(1):11-8. PubMed ID: 6423015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic and angiocardiographic changes following nitroglycerin in coronary artery disease.
    Suarez de Lezo J; Carrasco JL; Núñez P; García E; Hernandez-Lattuf P
    Eur J Cardiol; 1977 Jun; 5(4):357-72. PubMed ID: 408139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid coronary vasodilation by nitroglycerin tapes.
    Hara M; Saikawa T; Tsunematsu Y; Maeda T; Inoue T; Koumatsu K; Ito K; Nawata T; Sakata T
    Jpn Heart J; 1996 Sep; 37(5):603-10. PubMed ID: 8973374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of nitroglycerin tolerance with diuretics.
    Mohanty N; Wasserman AG; Walker P; Katz RJ
    Am Heart J; 1995 Sep; 130(3 Pt 1):522-7. PubMed ID: 7661070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers.
    Hiremath AN; Hoffman BB; Blaschke TF
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional and systemic hemodynamic and humoral effects of transdermal nitroglycerin in mild hypertension.
    Pedrinelli R; Graziadei L; Panarace G; Duranti P; Motolese M; Salvetti A
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):636-41. PubMed ID: 2478778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of transdermal nitroglycerin in children with congestive heart failure: a Doppler echocardiographic study.
    Vaksmann G; Pariente-Khayat A; Godart F; Francart C; Rey E; D'Athis P; Pons G; Rey C
    Pediatr Cardiol; 2001; 22(1):11-3. PubMed ID: 11123120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
    Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
    Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of sublingual nitroglycerin on the digital circulation of man.
    Burch GE
    Angiology; 1986 Nov; 37(11):801-9. PubMed ID: 3098140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radionuclide analysis of the forearm venous pressure-volume relationship: response to nitroglycerin.
    Dittrich HC; Slutsky RA
    Am Heart J; 1984 Apr; 107(4):733-7. PubMed ID: 6322562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different susceptibilities to the development of nitroglycerin tolerance in the human peripheral venous and arterial circulations].
    Ghio S; De Servi S; Perotti R; Eleuteri E; Montemartini C; Specchia G
    Cardiology; 1994; 84 Suppl 1():64-70. PubMed ID: 8087826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methionine restores the venodilative response to nitroglycerin after the development of tolerance.
    Levy WS; Katz RJ; Wasserman AG
    J Am Coll Cardiol; 1991 Feb; 17(2):474-9. PubMed ID: 1899435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of transdermal therapeutic system-nitroglycerin in patients with heart failure. Influence on hemodynamic changes.
    Ino-Oka E; Takishima T; Onodera K; Kato M; Hayashi M; Yasui S
    Jpn J Med; 1989; 28(6):697-708. PubMed ID: 2517442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of the effects of nitroglycerin on forearm circumference, with simultaneous recordings of arterial and venous diameters and blood pressure.
    Oshibuchi R; Ueno A
    Jpn Heart J; 1997 May; 38(3):409-17. PubMed ID: 9290575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of aldehyde dehydrogenase 2 gene polymorphism on hemodynamics after nitroglycerin intervention in Northern Chinese Han population.
    Xia JQ; Song J; Zhang Y; An NN; Ding L; Zhang Z
    Chin Med J (Engl); 2015 Jan; 128(2):180-5. PubMed ID: 25591559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of aspirin on the hemodynamic effects of sublingual nitroglycerin.
    Weber S; Rey E; Pipeau C; Lutfalla G; Richard MO; Daoud-El-Assaf H; Olive G; Degeorges M
    J Cardiovasc Pharmacol; 1983; 5(5):874-7. PubMed ID: 6195479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
    Jhund PS; Davie AP; McMurray JJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1234-8. PubMed ID: 11300428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.